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This investigation elucidated the role of free radicals in doxorubicin-induced toxicity and protection by 
Nardostachys jatamansi (NJ). Adult male albino wistar rats were administered with doxorubicin (15 
mg/kg; i.p.) and NJ (500 mg/kg, orally) for seven days. At the end of the experiment, following 
decapitation, heart and liver tissue samples were taken for histological examination, determination of 
malondialdehyde (MDA), glutathione (GSH) and myeloperoxidase (MPO) activity. In addition, 
proinflammatory cytokine (TNF-α) was assayed in plasma samples. The results reveal that doxorubicin 
caused a significant decrease in GSH level, significant increases in MDA level and MPO activity. 
Similarly, plasma cytokine level was elevated in doxorubicin group compared with the control group. On 
the other hand NJ pretreatment reversed all these biochemical indices. The results demonstrate that NJ 
extract, by balancing the oxidant-antioxidant status and inhibiting the generation of proinflammatory 
cytokine, protects against doxorubicin-induced oxidative organ injury. 
 





Doxorubicin (DOX) is a quinine-containing anticancer 
antibiotic and widely used to treat different types of 
human neoplastic disease such as hematopoietic, lym-
phoblastic and solid tumors (Hassanpour et al., 2010). 
However, its clinical use is limited on account of its 
toxicity. DOX cytotoxic effects have been associated with 
reactive oxygen species (ROS) generated during drug 
metabolism. Several in vivo and in vitro studies have 
demonstrated that reactive oxygen metabolites including 
free radical species, superoxide anion (O2−•), hydrogen 
peroxide (H2O2) and hydroxyl radical (•OH) are important 
mediators of tissue injury (Mohamad et al., 2009). The 
cellular and biochemical changes involved in this process 
have been demonstrated. One-electron reduction of DOX 
leads to formation of the corresponding semiquinone free 
radical. In the presence of oxygen, this free radical 
rapidly donates its electron to oxygen to generate 
superoxide anion (O2 •). The dismutation of superoxide 
yields hydrogen peroxide (H2O2). Under biological 
conditions, the anthracycline semiquinone or reduced 
metal ions such as iron reductively cleaves hydrogen 
peroxide to produce the hydroxyl radical which is the 
most reactive and destructive chemical species ever 
known. This ultimately leads to lipid peroxidation, causing 
irreversible damage of membrane structure and function 
(Giri et al., 2004). 
An extract of the rhizomes of Nardostachys jatamansi 
mainly composed of sesquiterpenes, lignans, neolignans, 
alkaloids and coumarins, has been shown to exhibit a 
variety of pharmacological actions (Subashini et al., 
2006). N. jatamansi extract (NJ) has been reported to be 
a potent free radical scavenger and an antioxidant. The 
extract of rhizome and its ingredients provide protection 
in myocardial and oxidative injury (Subashini et al., 2006; 
Ali et al., 2000). The antioxidant effects of NJ in doxoru-
bicin toxicity, was shown previously (Lyle et al., 2009).
 









Accordingly, the present study aimed to investigate the 
possible protective effect of NJ against doxorubicin 
induced oxidative damage of the heart and liver tissues 
by using biochemical approaches, such as the measure-
ment of malondialdehyde (MDA), glutathione (GSH) 
levels and myeloperoxidase (MPO) activity as well as by 
the histological analysis of tissue injury. 
 
 
MATERIALS AND METHODS 
 
Plant material and decoction preparation 
 
Roots of N. jatamansi De Jones (Valerianaceae) were identified 
and authenticated by Dr. Sasikala Ethirajulu, (Research Officer, 
Botany) of the Central Institute for Siddha (CRIS), Arumbakkam, 
Chennai-600 101. Clean roots were air dried and powdered to 
prepare the alcoholic extract as earlier described (Prabhu et al., 
1994). 1 kg of moderately powdered rhizomes of Jatamansi was 
extracted by refluxing with 95% ethyl alcohol in Soxhlet extractor for 
6-8 h. The extract was evaporated to dryness under reduced 
pressure and temperature using rotatory vacuum evaporator, and 
dried residue was stored at 4°C. The yield of dry extract from crude 
powder of Jatamansi was 10%. The dried ethanolic extract was 
suspended in distilled water which was then administered to rats 
orally at an optimum dosage of 500 mg/kg body wt. This particular 
dosage was fixed after trying out different doses for different days in 





Adult male Albino rats of Wistar strain weighing about 120 - 130 g 
were used in this study. They were maintained in clean, sterile, 
polypropylene cages and fed with commercial pelleted rat chow 
(M/s. Hindustan Lever Ltd., Bangalore, India), water ad libitum. 
Experimental animals were handled according to the University and 
institutional legislation, regulated by the Committee for the Purpose 
of Control and Supervision of Experiments on Animals (CPCSEA), 




Induction of experimental toxicity and treatment 
 
The following groups of animals were used. The rats were divided 
into four groups (n=6 in each group):  Group I: Rats served as the 
control; Group II: Rats were given doxorubicin (15 mg / kg body wt., 
intraperitoneally) on day 7 (Nagi and Mansour, 2000; Abdel-Wahab, 
2003), Group III: Rats were pretreated orally with NJ extract 
(500 mg /kg body wt., orally for 7days), Group IV: Rats were 
pretreated orally with NJ extract at the above mentioned dosage for 
seven days and were given doxorubicin (15 mg / kg body wt., 
intraperitoneally) on day 7. The animals were sacrificed after 48 h 
of experimental period. The blood was collected and plasma 
separated by centrifugation at 2500 g. The heart and liver tissue 
were dissected out and washed in ice-cold saline. A portion of the 
heart and liver tissue were homogenized in 0.1 M Tris-HCl buffer, 





MPO activity was measured in tissues by a procedure similar to that 
documented by Vaghasiya et al., 2010, MDA formation was 





glutathione was determined by the method of Moron et al. (1979), 
and plasma levels of TNF-α was determined by using an enzyme-






A small portion of the liver and heart tissue from the control and 
experimental animals were fixed in 10% neutral buffered formalin 
and processed by standard procedure for paraffin embedding and 
serial sections were cut (5 µM). The sections were stained with 





The values were expressed as mean ± SD for six rats in each group. 
All data’s were analyzed with SPSS/10 student software. 
Hypothesis testing method included one way analysis of variance 
(ANOVA) followed by post hoc testing performed for inter group 
comparison with least significant difference (LSD) test. The values 




RESULTS AND DISCUSSION 
 
Doxorubicin exposure is associated with several toxic 
manifestations in humans and laboratory animals, in 
which heart, liver and kidney being the most sensitive 
(Mohamed et al., 2004). The results of the present study 
indicate that administration of DOX in a dose of 15 mg/kg, 
i.p. significantly elevated the cardiac and liver tissue 
content of MDA, and a significant decrease of GSH level. 
Studying the toxic effects of doxorubicin in mice pre-
viously, demonstrated that when administered chronically, 
doxorubicin caused multiorgan damage by increasing 
lipid peroxidation of the tissues (Hrelia et al., 2002). 
Furthermore when Gingko biloba extract was adm-
inistered concomitantly with doxorubicin, this damage 
was prevented, suggesting that doxorubicin caused 
oxidative injury and that antioxidative agents could be 
beneficial against doxorubicin toxicity (Naidu et al., 2002).  
As a free radical generating system, lipid peroxidation 
has been suggested to be closely related to oxidant-
induced tissue damage, and MDA is a good indicator of 
the degree of lipid peroxidation (Vuchetich et al., 1996). 
In this study, it was observed that doxorubicin 
administration resulted in a significant increase in MDA 
levels in tissues (heart and liver) compared with the 
control animals.  
However, these elevations were significantly reversed 
with NJ administration (p < 0.05) (Tables 1 and 2). The 
association between elevated cardiac and liver tissue 
content of MDA and lowered cardiac content of GSH, 
found in this study, strongly proves the oxidative damage 
caused by DOX. This observation has been supported by 
previous findings (Yilmaz et al., 2006; Injac
 
et al., 2008). 
As shown in this study, the antioxidant NJ treatment 
significantly inhibited MDA production with a concomitant
 




Table 1. Effect of NJ on cardiac content of reduced glutathione (GSH) and 
melandialdhde (MDA) following doxorubicin administration 
 
Parameter GSH (μmol/g tissue) MDA (nmol/g protein) 
Control 4.5 ± 0.05 51.3 ± 1.55 
DOX 2.8 ± 0.03* 90.0 ± 1.70* 
NJ treated 4.7 ± 0.07 45.6 ± 1.04 
NJ + DOX treated group 3.2 ± 0.09* 48.4 ± 1.39* 
 
Data’s are expressed as mean ± SD; n=6. One way ANOVA was followed by post 
hoc test LSD, *P < 0.05, (Comparisons: control vs DOX induced group; DOX induced 




Table 2. Effect of NJ on Liver tissue content of reduced glutathione (GSH) and 
melandialdhde (MDA) following doxorubicin administration. 
 
Parameter GSH (μmol/g tissue) MDA (nmol/g protein) 
Control 1.96 ± 0.12 48.36 ± 1.91 
DOX  0.83 ± 0.01* 81.05 ± 3.72* 
NJ treated 1.98 ± 0.18 50.61 ± 2.00 
NJ + DOX treated group 1.45 ± 0.17* 60.43 ± 3.80* 
 
Data’s are expressed as mean ± SD; n=6. One way ANOVA was followed by post 
hoc test LSD, *P < 0.05, (Comparisons: control vs DOX induced group; DOX induced 




Table 3. The effects of doxorubicin and Nardostachys jatamansi extract 
(NJ) treatment on the myeloperoxidase activity (MPO) of the heart and 
liver tissues of groups. 
 
Parameter MPO in heart (U/g) MPO in liver (U/g) 
Control 0.62 ± 0.03 12.36 ± 1.41 
DOX  6.34 ± 0.20* 28.05 ± 2.90* 
NJ treated 0.60 ± 0.08 11.93 ± 1.82 
NJ + DOX treated group 3.98 ± 0.71* 15.70 ± 1.87* 
 
Data’s are expressed as mean ± SD; n=6. One way ANOVA was followed by 
post hoc test LSD, *P < 0.05, (Comparisons: control vs. DOX induced group; 




replenishment of tissue GSH content, implying a 
reduction in lipid peroxidation and cellular injury, which 
protects the heart and liver tissues against doxorubicin-
induced oxidative damage. An increase in MPO activity 
due to doxorubicin may cause inflammation and damage 
in the organs. MPO activity, which is an indicator of tissue 
neutrophil infiltration, was increased in all the studied 
tissues due to doxorubicin (p < 0.05) and NJ significantly 
reduced the tissue MPO activity (p < 0.05) (Table 3).  
It has been suggested that an increase in lipid 
peroxidation may be due partly to the free radicals 
generated by neutrophils because activated neutrophils 
are known to induce tissue injury through the production 
and release of reactive oxygen metabolites and cytotoxic 
proteins into the extracellular fluid. When neutrophils are 
stimulated by various stimulants, myeloperoxidase, as 
well as other tissue-damaging substances, is released 
from the cells (Kettle and Winterbourn, 1997).  
On the other hand, the proinflammatory cytokine, TNF-
alpha, was found to be significantly increased, also 
verifying that doxorubicin toxicity is closely related with 
inflammatory mechanisms and oxidative damage (Figure 
1). These observations have been supported by previous 
findings (Naiyra et al., 2010).  
Since NJ treatment significantly decreased these cyto-
kines and prevented the infiltration of neutrophils into the 
damaged tissue, the results suggest that the protective 
effects of NJ were mediated in part by blocking plasma 
cytokines and tissue neutrophil infiltration. This might also 
result in reduced lipid peroxidation and less accumulation
 






Figure 1. The effects of doxorubicin and Nardostachys jatamansi extract (NJ) treatment on the plasma levels of TNF-α. Group 1: 
Control; Group II, DOX induced; Group III, NJ treated; Group IV, NJ + DOX treated; Units: pg/ml. Values are expressed as mean ± SD; 
n=6. One way ANOVA was followed by post hoc test LSD. 
c




of MDA since activation of neutrophils might lead to the 
generation of oxygen reactive metabolites (Kettle and 
Winterbourn, 1997). 
The histological results also verified the doxorubicin 
induced oxidative injury, as demonstrated by biological 
parameters. Figure 3 A-D shows the histological pictures 
of the liver cells of experimental animals. The histological 
examination of control rats showed normal architecture 
when viewed under the microscope.  
The liver cells from the rats pretreated with NJ alone 
also revealed normal architecture when viewed under the 
microscope. Histological examination of hepatocytes from 
DOX treated rats showed vacuolar degenerative changes, 
focal necrosis, and increased kupfur cell activity, was 
also observed. In rats pretreated with NJ and adminis-
tered with DOX, there was reduced overall degeneration 
where mild hepatocellular degeneration persisted. 
Figure 2 A-D shows the histological pictures of the 
cardiac cells of experimental animals. The histological 
examination of the control rats showed normal archi-
tecture when viewed under the microscope.  
The cardiac cells from the rats pretreated with NJ alone 
also revealed normal architecture when viewed under the 
microscope. Histological examination of cardiac cells 
from DOX treated rats showed myocardial coagulative 
necrosis, vascular dilatation and inflammatory cellular 
infiltration and fibrosis. Rats pretreated with NJ and 
administered with DOX, showed lesser cellular infiltration, 
and less myocardial necrosis than DOX-treated rats. 
In the present study, increases in lipid peroxidation and 
myeloperoxidase activity due to the toxic effects of 
doxorubicin were accompanied by significant reductions 
in glutathione levels of the hepatic and cardiac tissues, 
suggesting the presence of oxidative tissue damage.  
Furthermore, the elevated plasma level of the cytokine 
TNF-α and the histological analyses demonstrated the 
severity of the doxorubicin induced systemic inflamma-
tory response. NJ as an antioxidant agent, amelio-rated 
the oxidative injury and inhibited the cytokine release.  
In conclusion, the protective effects of NJ can be 
attributed, at least in part, due to its free radicals 
scavenging capability, ability to inhibit neutrophil infil-
tration and to regulate the generation of inflammatory 
mediators, suggesting a future role in the treatment of 
multiorgan damage due to drug or chemical toxicities. On 
the basis of our findings, it may be worthy to suggest the 
































Figure 2. Histopathological changes of cardiac muscle tissue. A. Cardiac muscle tissue of control rats 
showing normal architecture H&E. B. Cardiac muscle tissue of DOX treated rats H&E. C. Cardiac 
muscle tissue of NJ treated rats showing apparently normal architecture H&E. D. Cardiac muscle tissue 






Figure 3. Histopathological changes of liver tissue. A. Liver of control rats showing 
normal architecture H&E. B. Liver of DOX treated rats H&E; C. Liver of NJ treated 
rats showing apparently normal architecture H&E. D. Liver of rats treated with 
DOX followed by NJ H&E. 
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